OR6Q1 Inhibitors
OR6Q1 inhibitors are a specialized class of chemical compounds that selectively target the olfactory receptor 6Q1 (OR6Q1), a member of the G protein-coupled receptor (GPCR) family. These inhibitors function by binding to the active site or allosteric sites of OR6Q1, thereby modulating its activity. The olfactory receptor OR6Q1 is involved in the detection of specific odorant molecules, and its inhibition can alter the signal transduction pathways associated with olfaction. The chemical structures of OR6Q1 inhibitors are designed to mimic or block the natural ligands of the receptor, enabling them to bind effectively and with high specificity. This selectivity is crucial for studying the receptor's role without affecting other olfactory receptors.
Research into OR6Q1 inhibitors focuses on understanding the molecular interactions between the inhibitor molecules and the receptor. Techniques such as computational modeling and molecular docking studies are employed to predict and analyze these interactions. Additionally, synthesis of these inhibitors involves organic chemistry methods that allow for the modification of molecular structures to enhance binding affinity and specificity. By investigating OR6Q1 inhibitors, scientists aim to elucidate the mechanisms of olfactory signal transduction and receptor activation. This research contributes to a broader understanding of sensory perception at the molecular level and supports the development of tools for studying the complex networks involved in olfaction.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might downregulate OR6Q1 expression by inhibiting NF-kB signaling, a pathway that can control the transcription of various olfactory receptor genes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could decrease OR6Q1 expression by enhancing the deacetylation of histones associated with the OR6Q1 gene promoter, leading to tighter chromatin and reduced transcription. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein may suppress OR6Q1 expression by acting as a tyrosine kinase inhibitor, leading to a decrease in phosphorylation events that trigger transcriptional activity for olfactory receptor genes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG could reduce OR6Q1 expression by inhibiting DNA methyltransferases, promoting hypomethylation of the OR6Q1 gene promoter and thus silencing the gene. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin may decrease OR6Q1 expression by inhibiting PI3K/Akt pathway, which is often involved in the transcriptional control of various genes, including those related to olfaction. | ||||||
Indole | 120-72-9 | sc-257606 sc-257606A sc-257606B sc-257606C sc-257606D | 25 g 100 g 250 g 1 kg 5 kg | $30.00 $69.00 $124.00 $270.00 $1301.00 | 3 | |
Indole-3-carbinol could downregulate OR6Q1 expression by altering the metabolism of estrogen, thus disrupting estrogen receptor-mediated transcription of the OR6Q1 gene. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine may reduce OR6Q1 expression by inhibiting cyclic nucleotide phosphodiesterases, leading to an increase in cAMP which can downregulate gene transcription in olfactory neurons. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid might suppress OR6Q1 expression by binding to retinoic acid receptors that heterodimerize with retinoid X receptors, leading to repression of target gene transcription. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 could downregulate OR6Q1 expression by binding to the vitamin D receptor, leading to the recruitment of co-repressors to the OR6Q1 promoter region and subsequent transcriptional repression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone might decrease OR6Q1 expression by activating glucocorticoid receptors which translocate to the nucleus and repress pro-inflammatory transcription factors that could be upregulating OR6Q1. | ||||||